Table 5.
Utilization of CBD in 428 patients with arthritis based on type of arthritis
| Osteoarthritis | Autoimmune arthritis | Rheumatoid arthritis | ||
|---|---|---|---|---|
| N (%) | N (%) | N (%) | P value | |
| Frequency | ||||
| <Once/month | 10 (4.9) | 2 (2.4) | 7 (4.9) | <.001* |
| Monthly | 6 (2.9) | 1 (1.2) | 8 (5.6) | |
| Weekly | 21 (10.3) | 2 (2.4) | 19 (13.4) | |
| Daily | 65 (31.9) | 22 (26.8) | 47 (33.1) | |
| >Once/day | 82 (40.2) | 29 (35.4) | 43 (30.3) | |
| Not specified | 20 (9.8) | 26 (31.7) | 18 (12.7) | |
| Duration | ||||
| <1 month | 14 (6.9) | 4 (4.9) | 19 (13.4) | .002* |
| 1–6 months | 52 (25.5) | 19 (23.2) | 26 (18.3) | |
| 6–12 months | 36 (17.6) | 15 (18.3) | 24 (16.9) | |
| 1–3 years | 49 (24) | 19 (23.2) | 36 (25.4) | |
| >3 years | 34 (16.7) | 3 (3.7) | 17 (12) | |
| Not specified | 19 (9.3) | 22 (26.8) | 20 (14.1) | |
| Daily dose | ||||
| ≤25 mg | 83 (40.7) | 30 (36.6) | 64 (45.1) | <.001* |
| 26-75 mg | 54 (26.5) | 21 (25.6) | 30 (21.1) | |
| >75mg | 49 (24) | 4 (4.9) | 27 (19) | |
| Not specified | 18 (8.8) | 27 (32.9) | 21 (14.8) | |
Mg milligrams, % percentage, < = less than, > = greater than, ≤ = less than or equal to
Statistical comparisons performed with Pearson chi-squared test between groups
*Significance determined as P<0.05